Ahmad & Sabbour note that most commonly reported adverse events were genital/urinary tract infections, gastrointestinal issues, and polyuria
[36] Clinical efficacy was demonstrated in the STEP trial program, a series of phase 3, randomized, double-blind, placebo-controlled studies
Its negative effects can include: Severe gastrointestinal symptoms Risk of thyroid C-cell tumors Pancreatitis Hypoglycemia Rybelsus (semaglutide) Rybelsus, another form of semaglutide, carries similar risks to Ozempic and Wegovy: Gastrointestinal discomfort Risk of thyroid tumors Pancreatic issues Low blood sugar levels Saxenda (liraglutide) Saxenda has been linked to: Thyroid tumors Pancreatitis Gallbladder problems Gastrointestinal issues Mounjaro (tirzepatide) Mounjaro is a newer weight loss drug with side effects that are still being studied
Well continue to increase your dose as needed to ensure you achieve the results youre looking for
2 Blue Cross and Blue Shield of Illinois recommends that GLP-1s should be used in coordination with other treatment strategies, like healthy eating, exercise, preventive care and more
